» Articles » PMID: 27705264

Polycystic Ovary Syndrome

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2016 Oct 6
PMID 27705264
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012-2023).

Wu R, Mai Z, Song X, Zhao W Front Microbiol. 2025; 15():1524521.

PMID: 39845049 PMC: 11753182. DOI: 10.3389/fmicb.2024.1524521.


Inulin-type fructans with different degrees of polymerization improve insulin resistance, metabolic parameters, and hormonal status in overweight and obese women with polycystic ovary syndrome: A randomized double-blind, placebo-controlled clinical....

Ziaei R, Shahshahan Z, Ghasemi-Tehrani H, Heidari Z, Nehls M, Ghiasvand R Food Sci Nutr. 2024; 12(3):2016-2028.

PMID: 38455215 PMC: 10916604. DOI: 10.1002/fsn3.3899.


PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway.

Yang X, A M, Gegen T, Daoerji B, Zheng Y, Wang A BMC Womens Health. 2024; 24(1):25.

PMID: 38184561 PMC: 10771674. DOI: 10.1186/s12905-023-02872-5.


Time-restricted eating: Watching the clock to treat obesity.

Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, Gabel K, Tussing-Humphreys L Cell Metab. 2024; 36(2):301-314.

PMID: 38176412 PMC: 11221496. DOI: 10.1016/j.cmet.2023.12.004.


Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study.

Srinivasan D, Lofton H Obes Pillars. 2023; 2:100016.

PMID: 37990710 PMC: 10661916. DOI: 10.1016/j.obpill.2022.100016.